https://publicatt.unicatt.it/handle/10807/140513
Stone composition and vascular calcifications in patients with nephrolithiasis
stonecompositionvascularcalcificationspatients
https://kidshealth.org/HumanaLouisiana/en/parents/kidney-stones.html
Kidney Stones (Nephrolithiasis) (for Parents) - Humana - Louisiana
Kidney stones are more common in adults, but kids can get them too. Learn the symptoms, treatments, and prevention.
kidney stonesfor parentsnephrolithiasishumanalouisiana
https://www.hmpgloballearningnetwork.com/site/frmc/articles/acp-recommendations-recurrent-nephrolithiasis
ACP Recommendations for Recurrent Nephrolithiasis
A systematic literature review was conducted to develop a clinical practice guideline for the dietary and pharmacologic management to prevent nephrolithiasis....
acprecommendationsrecurrentnephrolithiasis
https://iris.univr.it/handle/11562/998721
[Uric acid nephrolithiasis]
uric acid nephrolithiasis
https://vantipderg.org/jvi.aspx?un=VTD-05014&volume=22&issue=3
Our Percutaneous Nephrolithotomy Experiences in Pediatric Nephrolithiasis [Van Med J]
percutaneous nephrolithotomyexperiencespediatricnephrolithiasisvan
https://www.webindia123.com/health/disease/kidney/kstones/index.htm
Kidney Stones, nephrolithiasis
Kidney Stones is one of the most common disorder of the urinary tract.
kidney stonesnephrolithiasis
https://westcoastkidney.com/treatments/kidney-stones/
Kidney Stone Treatment in Bay Area | Nephrolithiasis Doctors
Oct 31, 2025 - Kidney stone treatment in Bay Area. Specialists provide diagnosis, removal, and prevention for lasting kidney stone relief.
kidney stone treatmentbay areanephrolithiasisdoctors
https://www.linksmedicus.com/news/target-trial-emulation-sglt-2-inhibitors-may-reduce-recurrent-nephrolithiasis-in-patients-with-type-2-diabetes-and-pre-existing-nephrolithiasis/
Target Trial Emulation: SGLT-2 Inhibitors May Reduce Recurrent Nephrolithiasis in Patients with...
Nov 10, 2024 - Background: Sodium-glucose cotransporter-2 (SGLT-2) inhibitors, initially approved for glycemic control in type 2 diabetes, have demonstrated multiple
may reducetargettrialemulationsglt